Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Thermo Fisher Scientific Inc

Symbol: TMO     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
0.27%
Current Price
$285.23
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 21:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
6,125,000,000
6,125,000,000
3,293,000,000
2,832,000,000
1,901,000,000
931,000,000
815,000,000
9,939,000,000
55,596,000,000
27,903,000,000
-
1,128,000,000
1,336,000,000
1,106,000,000
18,148,000,000
-957,000,000
649,000,000
 
248,000,000

Financials 2018

Update: 2019-06-10 21:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
6,507,000,000
6,507,000,000
3,583,000,000
2,924,000,000
1,761,000,000
1,163,000,000
898,000,000
10,625,000,000
56,232,000,000
28,646,000,000
27,586,000,000
2,117,000,000
1,271,000,000
2,103,000,000
18,990,000,000
1,067,000,000
1,801,000,000
 
251,000,000

Q 3

2018-09-30
5,920,000,000
5,920,000,000
3,305,000,000
2,615,000,000
1,730,000,000
885,000,000
709,000,000
9,566,000,000
55,078,000,000
28,188,000,000
26,890,000,000
1,111,000,000
1,014,000,000
1,098,000,000
18,774,000,000
176,000,000
1,220,000,000
 
240,000,000

Q 2

2018-06-30
6,078,000,000
6,078,000,000
3,340,000,000
2,738,000,000
1,784,000,000
954,000,000
752,000,000
9,474,000,000
55,403,000,000
28,958,000,000
26,445,000,000
956,000,000
1,711,000,000
937,000,000
19,420,000,000
253,000,000
1,444,000,000
 
242,000,000

Q 1

2018-03-31
5,853,000,000
5,853,000,000
3,273,000,000
2,580,000,000
1,749,000,000
831,000,000
579,000,000
9,588,000,000
56,580,000,000
30,457,000,000
26,123,000,000
975,000,000
2,814,000,000
950,000,000
20,936,000,000
-443,000,000
78,000,000
 
234,000,000

Financials 2017

Update: 2019-06-10 21:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
6,047,000,000
6,047,000,000
3,379,000,000
2,668,000,000
1,701,000,000
967,000,000
528,000,000
9,421,000,000
56,669,000,000
31,256,000,000
25,413,000,000
1,361,000,000
2,135,000,000
1,335,000,000
21,008,000,000
439,000,000
1,866,000,000
 
234,000,000